E-mail lunthesis@163.com Phone 0551-65179860-203

Indonesia approves emergency use of China's Zifivax COVID-19 vaccine

Pub Date:2021-10-08 08:28 Source:Xinhua

Indonesia's drug and food authority BPOM said Thursday it has issued an emergency use authorization (EUA) for the Zifivax COVID-19 vaccine produced by Chinese biopharmaceutical company Anhui Zhifei Longcom.

"Today, BPOM again announces that we have approved a COVID-19 vaccine product under the trade name Zifivax which was developed with a recombinant protein sub-unit platform," BPOM's head Penny Lukito told a virtual press conference.

Lukito explained that the Zifivax vaccine has passed the third phase of clinical trials with 28,500 subjects in Indonesia, Uzbekistan, Pakistan, Ecuador, and China.

In Indonesia, the third phase of the clinical trial involved around 4,000 people aged between 18 and 59 years old.

The clinical trial concluded that the efficacy of the Zifivax vaccine reached 81.71 percent after seven days of injections and 81.4 percent after 14 days.

Zifivax is also effective against the new variants of the SARS CoV-2 virus, namely Alfa (92.93 percent), Gamma (100 percent), Delta (77.47 percent), and Kappa (90.0 percent).

This is the tenth vaccine that has received an emergency use permit from the Indonesian government. Enditem


Related News
- China lowers cost of COVID-19 nucleic acid test    2021-09-18 14:54
- Government gives rural doctors' prospects a boost    2021-09-08 10:40
- China reduces COVID-19 medium-risk areas to three    2021-09-08 10:33
- Nearly 2.11 bln doses of COVID-19 vaccines administered i...    2021-09-06 16:26
photo  >>
Fill your spring scenery collection in Anhui
People enjoy themselves at eco-tourism scenic spot in Balidian, E China's Zhejiang
Video  >>
Volkswagen manager: I believe Chinese modernization is the right way
Let's meet inheritors: Luzhou dough modeling
People  >>
Sixty years on, hero soldier remains a role model in China
50 Years Friendship between China and Australia: Australian economist Tim Harcourt
Travel  >>
Iconic pine on China's Huangshan Mountain undergoes comprehensive examination
China sees over 73 mln domestic tourist visits during Mid-Autumn Festival holiday
Contact Us
Copyright ©2000-2021 anhuinews.com All rights reserved. Reproduction in whole or in part without permission is prohibited. 皖B2-20080023-7